Beam Therapeutics Inc.
BEAM
$31.58
-$0.17-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -94.32M | 244.30M | -112.73M | -102.29M | -108.33M |
| Total Depreciation and Amortization | 5.61M | 5.67M | 5.56M | 5.54M | 5.53M |
| Total Amortization of Deferred Charges | 35.00K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.78M | -231.39M | 32.81M | 16.86M | 24.39M |
| Change in Net Operating Assets | -55.62M | -101.86M | -7.12M | 3.44M | -25.47M |
| Cash from Operations | -128.51M | -83.29M | -81.48M | -76.45M | -103.88M |
| Capital Expenditure | -2.23M | -3.73M | -5.01M | -3.14M | -3.07M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | -78.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.50M | 112.14M | 70.74M | -167.28M | -122.02M |
| Cash from Investing | 25.27M | 108.41M | 65.66M | -170.41M | -125.09M |
| Total Debt Issued | 93.89M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.54M | 1.89M | 1.68M | 1.11M | 473.38M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -813.00K | -- | -- | -- | -- |
| Cash from Financing | 96.61M | 1.89M | 1.68M | 1.11M | 473.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.64M | 27.00M | -14.15M | -245.75M | 244.41M |